Bacharier LB, Maspero JF, Papadopoulos NG, Gagnon R, et al. Dupilumab Plus Medium-Dose Inhaled Corticosteroid (ICS) Improves Outcomes Compared With Placebo Plus Continued High-Dose ICS in Children With Uncontrolled Moderate-to-Severe Type 2 Asthma. Pediatr Pulmonol 2025;60:e71197.
PMID: 40728026